Bristol Financial Statements From 2010 to 2024
| BMYB34 Stock | BRL 341.31 0.39 0.11% |
Check Bristol Myers financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bristol Myers' main balance sheet or income statement drivers, such as , as well as many indicators such as . Bristol financial statements analysis is a perfect complement when working with Bristol Myers Valuation or Volatility modules.
Bristol |
Bristol Myers Squibb Company Operating Margin Analysis
Bristol Myers' Operating Margin shows how much operating income a company makes on each dollar of sales. It is one of the profitability indicators which helps analysts to understand whether the firm is successful or not making money from everyday operations.
Current Bristol Myers Operating Margin | 0.20 % |
Most of Bristol Myers' fundamental indicators, such as Operating Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Bristol Myers Squibb is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
A good Operating Margin is required for a company to be able to pay for its fixed costs or payout its debt, which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against a firm's competitors.
| Competition |
Based on the recorded statements, Bristol Myers Squibb has an Operating Margin of 0.1972%. This is 100.56% lower than that of the Healthcare sector and 99.02% lower than that of the Drug Manufacturers - Major industry. The operating margin for all Brazil stocks is 103.58% lower than that of the firm.
Bristol Myers Squibb Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Bristol Myers's current stock value. Our valuation model uses many indicators to compare Bristol Myers value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Bristol Myers competition to find correlations between indicators driving Bristol Myers's intrinsic value. More Info.Bristol Myers Squibb is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers reporting about 0.33 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Bristol Myers Squibb is roughly 3.01 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Bristol Myers by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bristol Myers' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Bristol Myers Financial Statements
Bristol Myers stakeholders use historical fundamental indicators, such as Bristol Myers' revenue or net income, to determine how well the company is positioned to perform in the future. Although Bristol Myers investors may analyze each financial statement separately, they are all interrelated. For example, changes in Bristol Myers' assets and liabilities are reflected in the revenues and expenses on Bristol Myers' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Bristol Myers Squibb. Please read more on our technical analysis and fundamental analysis pages.
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York. BRISTOLMYERSDRN operates under Drug Manufacturers - Major classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 23300 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Bristol Stock
When determining whether Bristol Myers Squibb offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bristol Myers' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bristol Myers Squibb Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bristol Myers Squibb Stock:Check out the analysis of Bristol Myers Correlation against competitors. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.